Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.

about

Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q47106745

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Local blockage of self-sustain ...... in non-small cell lung cancer.

@en

Local blockage of self-sustain ...... in non-small cell lung cancer.

@nl

type

Item

label

Local blockage of self-sustain ...... in non-small cell lung cancer.

@en

Local blockage of self-sustain ...... in non-small cell lung cancer.

@nl

prefLabel

Local blockage of self-sustain ...... in non-small cell lung cancer.

@en

Local blockage of self-sustain ...... in non-small cell lung cancer.

@nl

P1476

Local blockage of self-sustain ...... in non-small cell lung cancer.

@en

P2093

Cun Zhang

http://www.w3.org/2001/XMLSchema#string

Elhadji M Dioum

http://www.w3.org/2001/XMLSchema#string

Jiming Zhou

http://www.w3.org/2001/XMLSchema#string

Kuo Zhang

http://www.w3.org/2001/XMLSchema#string

Lei He

http://www.w3.org/2001/XMLSchema#string

Lijuan Zhao

http://www.w3.org/2001/XMLSchema#string

Meng Li

http://www.w3.org/2001/XMLSchema#string

Qiang Hao

http://www.w3.org/2001/XMLSchema#string

Qiuyang Zhang

http://www.w3.org/2001/XMLSchema#string

Shouzhen Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Angiogenesis in cancer and other diseases

Basic and therapeutic aspects of angiogenesis

Erythropoietin: physiology and pharmacology update.

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.

Epoetin beta for the treatment of chemotherapy-induced anemia: an update.

Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.

Recombinant mutated human TNF in combination with chemotherapy for stage IIIB/IV non-small cell lung cancer: a randomized, phase III study.

Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer.

P304

82352-82365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19354

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29137269

http://www.w3.org/2001/XMLSchema#string

P921

Erythropoietin

P932

5669895

http://www.w3.org/2001/XMLSchema#string